Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cystitis AND Urinary Tract Infection

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    24 result(s) found for: Cystitis AND Urinary Tract Infection. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2013-003327-11 Sponsor Protocol Number: 3623 Start Date*: 2015-02-10
    Sponsor Name:University of Southampton
    Full Title: Alternative Treatments of Adult female Urinary Tract Infection: a double blind, placebo controlled,factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen.
    Medical condition: Acute urinary tract infections.
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004862 10000698 Acute cystitis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-005706-11 Sponsor Protocol Number: Cyst2016_01 Start Date*: 2016-03-14
    Sponsor Name:Vita Green Europa S.A.
    Full Title: Single-site, open, randomized clinical trial to assess the non-inferiority of Cysticlean® versus Fosfomicina in the treatment of cystitis in women in Spain.
    Medical condition: Urinary Tract Infection (UTI)
    Disease: Version SOC Term Classification Code Term Level
    18.1 10021881 - Infections and infestations 10011790 Cystitis escherichia PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2018-001448-78 Sponsor Protocol Number: Cyst2018_01 Start Date*: 2018-11-08
    Sponsor Name:Vita Green Europa S.A.
    Full Title: Single-site, open, randomized clinical trial to assess the non-inferiority of Cysticlean® versus Fosfomicina in the treatment of cystitis in women in Spain.
    Medical condition: Urinary Tract Infection (UTI)
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10011790 Cystitis escherichia PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-003367-23 Sponsor Protocol Number: 672-CL-035 Start Date*: 2006-02-13
    Sponsor Name:Astellas Pharma Europe B.V.
    Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of YM672 in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis
    Medical condition: Interstitial Cystitis / Painful Bladder Syndrome
    Disease: Version SOC Term Classification Code Term Level
    8.0 10008928 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) SE (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2020-000553-27 Sponsor Protocol Number: 212390 Start Date*: 2020-06-24
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin...
    Medical condition: Urinary Tract Infection (Acute Cystitis)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: BG (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2012-002776-14 Sponsor Protocol Number: 97 Start Date*: 2013-03-15
    Sponsor Name:University of Oslo, Faculty of medicine, Institute of Health and Society
    Full Title: Ibuprofen versus mecillinam for uncomplicated cystitis in adult, non-pregnant women
    Medical condition: Uncomplicated cystitis in adult, non pregnant women, age 18-60.
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004862 10000699 Acute cystitis (excl in pregnancy) LLT
    Population Age: Adults Gender: Female
    Trial protocol: NO (Completed) DK (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2010-022096-54 Sponsor Protocol Number: Repha_1344 Start Date*: 2011-04-04
    Sponsor Name:Repha GmbH
    Full Title: Randomised, prospective, double-dummy double-blinded study to evaluate safety and efficacy of Angocin Anti-Infekt N versus standard antibiotics in the treatment of acute uncomplicated cystitis
    Medical condition: Treatment of acute uncomplicated cystitis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2018-001801-98 Sponsor Protocol Number: 204989 Start Date*: 2020-02-27
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin...
    Medical condition: Urinary Tract Infection (Acute Cystitis)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) BG (Completed) GR (Completed) HU (Completed) CZ (Completed) SK (Completed) RO (Ongoing)
    Trial results: View results
    EudraCT Number: 2016-001427-30 Sponsor Protocol Number: 276046 Start Date*: 2016-06-28
    Sponsor Name:University of Helsinki / CLUE Working Group
    Full Title: Antibiotic prophylaxis before extracorporeal shock wave lithotripsy (APPEAL)
    Medical condition: Prevention of urinary tract infections among patients undergoing extracorporeal shock wave lithotripsy for urinary stone disease
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004862 10046574 Urinary tract infection NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-005559-19 Sponsor Protocol Number: FUR-03-17 Start Date*: 2021-02-23
    Sponsor Name:ADAMED Pharma S.A.
    Full Title: FRUTI - a phase III, randomized, multicenter, double-blind, active control study to evaluate the efficacy and safety of Furazidin prolonged-release tablets, 200 mg compared with Nitrofurantoin prol...
    Medical condition: uncomplicated lower urinary tract infections (acute or recurrent)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10046577 Urinary tract infections HLT
    20.0 10021881 - Infections and infestations 10046571 Urinary tract infection PT
    20.0 10021881 - Infections and infestations 10024981 Lower urinary tract infection LLT
    20.0 10021881 - Infections and infestations 10038140 Recurrent urinary tract infection LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: PL (Completed) HU (Completed) DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-001486-21 Sponsor Protocol Number: 276046 Start Date*: 2021-11-26
    Sponsor Name:University of Helsinki/CLUE working Group
    Full Title: A Multicentre Randomised Control Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on reducing Urinary Tract Infections
    Medical condition: Nephrolithiasis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10046574 Urinary tract infection NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-004594-82 Sponsor Protocol Number: CSU11001 Start Date*: 2012-01-17
    Sponsor Name:Schur Pharmazeutika GmbH & Co. KG
    Full Title: Efficacy of an intravesical instillation with neomycin solution in acute cystitis: a double-blind, placebo-controlled trial in patients with permanent intravesical catheter
    Medical condition: Treatment of urinary tract infection
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10046571 Urinary tract infection PT
    14.1 10021881 - Infections and infestations 10046577 Urinary tract infections HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2012-000938-19 Sponsor Protocol Number: 4PH/2012/002 Start Date*: 2012-06-11
    Sponsor Name:NOVINTETHICAL PHARMA SAGL
    Full Title: Safety and Efficacy of tablets containing extract of Hibiscus Sabdariffa (HS) and Propoli versus placebo in the treatment of the cystitis with Ciproxin
    Medical condition: patients with diagnosys of cystitis confirmed by urine culture
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10021881 Infections and infestations SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-000963-54 Sponsor Protocol Number: FUR-PKPD-05-20 Start Date*: Information not available in EudraCT
    Sponsor Name:Adamed Pharma S.A.
    Full Title: Effectiveness and pharmacokinetic /pharmacodynamic study of Furazidin, prolonged- release tablets, 200 mg in the treatment of patients with uncomplicated lower urinary tract infections (acute or re...
    Medical condition: uncomplicated lower urinary tract infections (acute or recurrent)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10046577 Urinary tract infections HLT
    20.0 10021881 - Infections and infestations 10046571 Urinary tract infection PT
    20.0 10021881 - Infections and infestations 10024981 Lower urinary tract infection LLT
    20.0 10021881 - Infections and infestations 10038140 Recurrent urinary tract infection LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: PL (Prematurely Ended) DE (Prematurely Ended) HU (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2021-003466-12 Sponsor Protocol Number: MCMK0220 Start Date*: 2022-03-25
    Sponsor Name:MCM Klosterfrau Vertriebsgesellschaft mbH
    Full Title: A double-blind, randomised, multi-centre, controlled clinical trial to compare D-mannose versus antibiotic in the treatment of acute uncomplicated lower urinary tract infections in female patients
    Medical condition: acute uncomplicated lower urinary tract infections
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10024981 Lower urinary tract infection LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-003857-26 Sponsor Protocol Number: BIRT Start Date*: 2013-12-11
    Sponsor Name:ULB ERASME HOSPITAL
    Full Title: The Bacteriuria In Renal Transplantation study: A prospective, randomized, multicenter trial comparing antibiotics versus no treatment in the prevention of urinary tract infection in kidney transpl...
    Medical condition: Asymptomatic bacteriuria after renal transplantation.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-000906-36 Sponsor Protocol Number: GEB-IAL-2014-01 Start Date*: 2014-12-09
    Sponsor Name:Laboratorios Gebro Pharma S.A.
    Full Title: Randomized, parallel, multicenter, phase IV clinical trial to assess the efficacy of hyaluronic acid/chondroitin sulfate versus fosfomycin trometamol in recurrent urinary tract infection prevention.
    Medical condition: Recurrent urinary tract infections
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-004174-10 Sponsor Protocol Number: P1351 Start Date*: 2013-11-18
    Sponsor Name:UMC St Radboud
    Full Title: Pharmacokinetics of nitrofurantoin in the elderly
    Medical condition: Uncomplicated urinary tract infection
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-002235-15 Sponsor Protocol Number: 999975814 Start Date*: 2020-01-22
    Sponsor Name:University of Oslo
    Full Title: The effect of methenamine hippurate to reduce antibiotic prescribing due to new episodes of urinary tract infections (UTI) in elderly women with recurrent UTI – a triple-blinded,randomized placebo-...
    Medical condition: recurrent urinary tract infection in women
    Disease:
    Population Age: Elderly Gender: Female
    Trial protocol: SE (Completed) NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-001838-17 Sponsor Protocol Number: MV140-SLG-003 Start Date*: 2015-07-17
    Sponsor Name:Inmunotek, S.L. [...]
    1. Inmunotek, S.L.
    2. INMUNOTEK, S.L.
    Full Title: PROSPECTIVE MULTICENTER CLINICAL TRIAL RANDOMIZED, DOUBLE-BLIND, PARALLEL-CONTROLLED VERSUS PLACEBO IN A POLYVALENT SUBLINGUAL BACTERIAL VACCINE (IN ORAL MUCOSA) TO THREE MONTHS AND SIX MONTHS IN ...
    Medical condition: Recurrent Urinary Tract Infections
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004862 10038140 Recurrent urinary tract infection LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing) GB (GB - no longer in EU/EEA)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 02 06:51:39 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA